DBVT
DBV Technologies
NASDAQ: DBVT · HEALTHCARE · BIOTECHNOLOGY
$21.00
+3.45% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
207.92x
EPS (TTM)
$-5.25
Dividend yield
—
52W range
$8 – $26
Volume
0.2M
DBV Technologies (DBVT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |